December 2019

Editorial 
How to add value to research?
Peter Kapitein
Precision Cancer Medicine  
2019;
2:
39  
Editorial Commentary 
Immunotherapy approaches to beat tumors
Alexandre Morrot
Precision Cancer Medicine  
2019;
2:
38  
Editorial 
Precision surgery, it matters
Marcelo Jimenez
Precision Cancer Medicine  
2019;
2:
37  
Review Article 
How to recognize and manage hyper-progression and pseudo-progression during immune checkpoint blockade in non-small cell lung cancer
Francesco Facchinetti, Giuseppe Lo Russo, Marcello Tiseo, Marina Chiara Garassino, Roberto Ferrara
Precision Cancer Medicine  
2019;
2:
35  
Review Article 
Lung cancer screening: where do we stand?
Fabrizio Minervini, Marco Scarci
Precision Cancer Medicine  
2019;
2:
34  
Review Article 
Precision medicine and future of cancer treatment
Chandrajit Lahiri, Shrikant Pawar, Rohit Mishra
Precision Cancer Medicine  
2019;
2:
33  
News 
Application of the CARE guideline as reporting standard in the Precision Cancer Medicine
Editorial Office
Precision Cancer Medicine  
2019;
2:
32  
Original Article 
Differences in optimal timing of post-surgical surveillance for limited stage lung cancer patients and associations with outcomes
Elizabeth Colwell, Jalen Benson, Prasha Bhandari, Hao He, Joseph Shrager, Natalie Lui, Mark Berry, Leah Backhus
Precision Cancer Medicine  
2019;
2:
31  
Original Article 
Data sharing in the era of precision medicine: a scientometric analysis
Vincent Le Texier, Nesrine Henda, Stéphanie Cox, Marina ousseau-Tsangaris, Pierre Saintigny
Precision Cancer Medicine  
2019;
2:
30